Form 4 for BVS Bioventus Inc.
Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-01 · accession 0000899243-22-013943 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-05 | 2022-04-01 | BVS | SUTTER MARTIN P | Dir | M - OptEx | — | +2,700 | 11.7K | +30% | — |
| D | 2022-04-05 | 2022-04-01 | BVS | SUTTER MARTIN P | Dir | M - OptEx | $0.00 | -2,700 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-04-01 | M | A | 2,700 | — | 11,700 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. |
| 2 | Derivative | Restricted Stock Units | 2022-04-01 | M | D | 2,700 | $0.00 | 0 | D | — · — to — | 2,700 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F3) The RSUs vested on April 1, 2022. |